Evommune, Inc. Common Stock (EVMN)

Cost of Revenue

$0.00

Quarterly · Period ending: · USD

EVMN logo

EVMN Cost of Revenue

Latest reported$0.00
EVMN Quarterly Cost of Revenue ($271.00K → $0.00)
High-resolution chart · PNG

EVMN cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Evommune, Inc. Common Stock Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
0
0
0
0
375,000
377,000
0
0
325,000
271,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.